(Q53595867)
Statements
Vasodilation by urapidil in the treatment of chronic congestive heart failure in addition to angiotensin-converting enzyme inhibitors is not beneficial: results of a placebo-controlled, double-blind study. (English)
Dorszewski A
Göhmann E
Dorsźewski B
Werner GS
Kreuzer H
Figulla HR
1 June 1997
3
2
91-96